Thursday 24 May 2018
Human Genome Sciences

GSK extends $2.6bn offer to key partner

GlaxoSmithKline has extended its $2.6 billion offer to buy long-time partner Human Genome Sciences until the end of June as it battles the US biotech company's reluctant management. The price remains unchanged at $13 a share under the 


US clears new lupus drug, major sales seen

The first new treatment for lupus in a half-century has won US approval, a milestone for patients with the disabling disease and a potential blockbuster for its tiny biotech maker. Health officials cleared Benlysta, discovered by Human Gen


Lupus drug trial reports success

Human Genome Sciences Inc said on Monday that its experimental lupus drug had succeeded in a late-stage clinical trial, shocking many who had written the product off as dead and fueling a 228 per cent stock jump. The results, which were an

 1 2 3 4 5 >  Last ›

calendarCalendar of Events